MedPath

GODAVARI BIOREFINERIES LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Phase One Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MSP008-22 in Healthy Adult Volunteers

Phase 1
Not yet recruiting
Conditions
COVID-19
Interventions
Other: Placebo
First Posted Date
2022-09-08
Last Posted Date
2022-09-08
Lead Sponsor
Godavari Biorefineries Limited
Target Recruit Count
72
Registration Number
NCT05532293
Locations
🇮🇳

K. J. Somaiya Hospital & Research Centre, Somaiya Ayurvihar Complex, Eastern Express Highway, Sion East, Mumbai, Maharashtra, India

Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours

Phase 1
Conditions
Advanced Solid Tumor
Interventions
First Posted Date
2022-07-28
Last Posted Date
2022-07-28
Lead Sponsor
Godavari Biorefineries Limited
Target Recruit Count
27
Registration Number
NCT05478486
Locations
🇮🇳

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) of TATA Memorial Centre, Navi Mumbai, Maharashtra, India

© Copyright 2025. All Rights Reserved by MedPath